Date published: 2026-3-3

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olfr741 Inhibitors

Olfr741, encoded by the Or11g25 gene, belongs to the olfactory receptor family and is a type of G-protein-coupled receptor (GPCR) found in mice. These receptors are essential for detecting odorant molecules and initiating neuronal responses that lead to the perception of smell. They operate by recognizing specific ligands (odorants) and activating G proteins, triggering a cascade of intracellular signaling events. These events often involve the production of secondary messengers like cyclic AMP (cAMP) and the activation of various downstream effectors, ultimately resulting in a physiological response. The inhibition of Olfr741, as with other olfactory receptors, is a multifaceted process due to the indirect nature of potential inhibitory mechanisms. In the absence of direct inhibitors, targeting associated signaling pathways offers a viable approach. Compounds that influence cAMP levels, such as forskolin (which stimulates cAMP production) or caffeine (which inhibits cAMP degradation), can lead to changes in GPCR activity. Elevated cAMP levels may result in receptor desensitization or downregulation, reducing the receptor's response to odorants.

Additionally, modulation of ion channel activity or neurotransmitter systems can also indirectly impact GPCR signaling. Calcium channel blockers like nifedipine and amlodipine can alter intracellular calcium levels, which are vital for GPCR function. Similarly, drugs affecting neurotransmitter dynamics, such as diazepam (enhancing GABAergic signaling) or memantine (antagonizing NMDA receptors), can indirectly influence the functioning of GPCRs like Olfr741 by altering the overall neurochemical environment. Furthermore, compounds that affect other signaling molecules, like NSAIDs (ibuprofen, aspirin) which modify prostaglandin synthesis, or nitric oxide donors influencing nitric oxide levels, provide alternative routes to indirectly influence GPCR activity. These alterations in signaling molecules can impact the functioning of olfactory receptors. In summary, the potential inhibition of Olfr741 involves a complex interplay of various biochemical pathways and cellular processes. Targeting components and pathways associated with GPCR signaling, such as manipulating cAMP levels, ion channel activities, neurotransmitter systems, and other signaling molecules, offers indirect methods to modulate the activity of olfactory receptors like Olfr741. Understanding these interactions is crucial for exploring potential strategies for influencing olfactory receptor function.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Caffeine

58-08-2sc-202514
sc-202514A
sc-202514B
sc-202514C
sc-202514D
50 g
100 g
250 g
1 kg
5 kg
$33.00
$67.00
$97.00
$192.00
$775.00
13
(1)

Caffeine, a phosphodiesterase inhibitor, elevates cAMP levels. Increased cAMP can lead to GPCR desensitization, potentially reducing Olfr741 responsiveness.

Ibuprofen

15687-27-1sc-200534
sc-200534A
1 g
5 g
$53.00
$88.00
6
(0)

Ibuprofen, an NSAID, inhibits cyclooxygenase enzymes. This can indirectly affect Olfr741 signaling by altering prostaglandin levels, which interact with GPCR pathways.

Aspirin

50-78-2sc-202471
sc-202471A
5 g
50 g
$20.00
$42.00
4
(1)

Aspirin inhibits cyclooxygenase, affecting prostaglandin synthesis. This alteration can indirectly influence Olfr741's GPCR-mediated signaling.

Nifedipine

21829-25-4sc-3589
sc-3589A
1 g
5 g
$59.00
$173.00
15
(1)

Nifedipine, a calcium channel blocker, may indirectly impact Olfr741 by modifying intracellular calcium, crucial for GPCR signaling.

Amlodipine

88150-42-9sc-200195
sc-200195A
100 mg
1 g
$74.00
$166.00
2
(1)

Amlodipine, another calcium channel blocker, could affect Olfr741 by changing calcium-dependent signaling processes in olfactory neurons.

PGE2

363-24-6sc-201225
sc-201225C
sc-201225A
sc-201225B
1 mg
5 mg
10 mg
50 mg
$57.00
$159.00
$275.00
$678.00
37
(1)

Prostaglandin E2 might indirectly influence Olfr741 by modulating GPCR-related pathways in olfactory signaling.

Acetazolamide

59-66-5sc-214461
sc-214461A
sc-214461B
sc-214461C
sc-214461D
sc-214461E
sc-214461F
10 g
25 g
100 g
250 g
500 g
1 kg
2 kg
$81.00
$177.00
$434.00
$541.00
$883.00
$1479.00
$2244.00
1
(1)

Acetazolamide, a carbonic anhydrase inhibitor, can alter pH balance, potentially impacting Olfr741 GPCR activity.

Memantine hydrochloride

41100-52-1sc-203628
50 mg
$69.00
4
(2)

Memantine, an NMDA receptor antagonist, could indirectly affect Olfr741 by altering glutamatergic signaling, which may influence GPCR activity.